SIDNEY SMITH: Open Payments
NPI 1922148162 · METAIRIE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,830 in 87 payments from 16 companies in 2025. Trend: 2023 $2,352 · 2024 $2,423 · 2025 $1,830
Food & beverage: $1,717Education: $113
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 15 | $356 |
| ABBVIE INC. | 15 | $276 |
| Teva Pharmaceuticals USA, Inc. | 11 | $194 |
| Alkermes, Inc. | 7 | $164 |
| Vanda Pharmaceuticals Inc. | 8 | $141 |
| Janssen Pharmaceuticals, Inc | 6 | $116 |
| Axsome Therapeutics, Inc. | 5 | $112 |
| Lundbeck LLC | 5 | $108 |
| Almatica Pharma LLC | 4 | $88 |
| Supernus Pharmaceuticals, Inc. | 2 | $69 |
Products named: REXULTI, VRAYLAR, ARISTADA, FANAPT, SPRAVATO, Auvelity, LOREEV XR, AUSTEDO XR.
Industry payments across LA — which companies pay providers there.
